Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Details for Australian Patent Application No. 2004265299 (hide)

Owner Merck & Co., Inc.

Inventors Kevin, Nancy J.; Gao, Ying-Duo; Waddell, Sherman T.; Gu, Xin

Agent Spruson & Ferguson

Pub. Number AU-B-2004265299

PCT Pub. Number WO2005/016877

Priority 60/493,487 07.08.03 US

Filing date 3 August 2004

Wipo publication date 24 February 2005

Acceptance publication date 1 May 2008

International Classifications

C07D 231/16 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016877 Priority application(s): WO2005/016877

1 May 2008 Application Accepted

  Published as AU-B-2004265299

28 August 2008 Standard Patent Sealed

3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265300-Sulfonyl substituted N-(biarylmethyl) aminocyclopropanecarboxamides

2004265298-Cyclic amine BACE-1 inhibitors having a benzamide substituent